2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
US7659280B2 · kind B2 · utility
18Cited by
8References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2007 |
| Grant date | Feb 9, 2010 |
| Priority date | — |
| Expiry date | Feb 16, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides 3-hydroxyphenyl-2,4-pyrimidinediamine compounds of formula I, as well as related compositions and methods for treating a variety of autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.